DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,115 filers reported holding DANAHER CORPORATION in Q3 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,702,285 | +2.2% | 27,014 | -1.2% | 0.51% | +5.0% |
| Q2 2023 | $6,560,256 | -5.5% | 27,334 | -0.7% | 0.48% | -10.6% |
| Q1 2023 | $6,939,503 | -7.2% | 27,533 | -2.3% | 0.54% | -12.4% |
| Q4 2022 | $7,481,471 | +6.8% | 28,187 | +3.9% | 0.62% | +3.0% |
| Q3 2022 | $7,007,000 | +1.2% | 27,129 | -0.6% | 0.60% | +5.9% |
| Q2 2022 | $6,921,000 | -13.4% | 27,301 | +0.2% | 0.56% | -1.6% |
| Q1 2022 | $7,995,000 | -9.2% | 27,258 | +1.9% | 0.57% | -7.0% |
| Q4 2021 | $8,804,000 | +5.9% | 26,759 | -2.0% | 0.62% | 0.0% |
| Q3 2021 | $8,310,000 | +12.3% | 27,297 | -1.0% | 0.62% | +11.0% |
| Q2 2021 | $7,400,000 | +17.8% | 27,575 | -1.2% | 0.56% | +8.8% |
| Q1 2021 | $6,280,000 | -15.8% | 27,900 | -16.9% | 0.51% | -20.6% |
| Q4 2020 | $7,457,000 | +98.5% | 33,570 | +92.5% | 0.64% | -12.2% |
| Q3 2020 | $3,756,000 | -38.5% | 17,442 | -49.5% | 0.73% | +12.8% |
| Q2 2020 | $6,104,000 | +30.2% | 34,518 | +1.9% | 0.65% | +8.4% |
| Q1 2020 | $4,689,000 | -10.5% | 33,878 | -0.8% | 0.60% | +8.9% |
| Q4 2019 | $5,240,000 | +5.3% | 34,140 | -0.9% | 0.55% | -3.0% |
| Q3 2019 | $4,975,000 | +1.0% | 34,445 | -0.1% | 0.57% | -2.2% |
| Q2 2019 | $4,927,000 | +9.2% | 34,474 | +0.9% | 0.58% | +4.7% |
| Q1 2019 | $4,510,000 | +24.8% | 34,161 | -2.5% | 0.55% | +9.9% |
| Q4 2018 | $3,614,000 | -6.1% | 35,042 | -1.0% | 0.50% | +5.2% |
| Q3 2018 | $3,847,000 | +9.4% | 35,400 | -0.6% | 0.48% | +2.8% |
| Q2 2018 | $3,515,000 | -0.1% | 35,623 | -0.8% | 0.46% | -2.7% |
| Q1 2018 | $3,518,000 | +3.1% | 35,927 | -2.3% | 0.48% | +2.6% |
| Q4 2017 | $3,413,000 | +6.3% | 36,768 | -1.8% | 0.47% | +2.0% |
| Q3 2017 | $3,211,000 | +1.2% | 37,431 | -0.5% | 0.46% | -6.2% |
| Q2 2017 | $3,174,000 | -2.4% | 37,615 | -1.0% | 0.49% | -5.8% |
| Q1 2017 | $3,251,000 | +5.0% | 38,010 | -4.4% | 0.52% | +4.2% |
| Q4 2016 | $3,095,000 | -1.7% | 39,755 | -1.1% | 0.50% | -4.8% |
| Q3 2016 | $3,150,000 | -23.5% | 40,181 | -1.4% | 0.52% | -25.8% |
| Q2 2016 | $4,116,000 | +4.5% | 40,751 | -1.9% | 0.70% | +0.7% |
| Q1 2016 | $3,940,000 | +2.4% | 41,531 | +0.2% | 0.70% | -1.4% |
| Q4 2015 | $3,849,000 | +8.3% | 41,440 | -0.7% | 0.71% | +2.8% |
| Q3 2015 | $3,555,000 | -2.5% | 41,720 | -2.1% | 0.69% | +1.6% |
| Q2 2015 | $3,647,000 | -2.1% | 42,615 | -2.9% | 0.68% | -2.9% |
| Q1 2015 | $3,725,000 | -1.3% | 43,870 | -0.4% | 0.70% | -2.5% |
| Q4 2014 | $3,775,000 | +15.9% | 44,045 | +2.8% | 0.72% | +13.7% |
| Q3 2014 | $3,256,000 | -5.0% | 42,860 | -1.6% | 0.63% | -6.0% |
| Q2 2014 | $3,429,000 | +1.5% | 43,549 | -3.3% | 0.67% | -2.0% |
| Q1 2014 | $3,378,000 | -3.2% | 45,043 | -0.3% | 0.68% | -9.1% |
| Q4 2013 | $3,488,000 | +9.0% | 45,181 | -2.2% | 0.75% | +1.6% |
| Q3 2013 | $3,201,000 | +8.6% | 46,181 | -0.8% | 0.74% | -3.7% |
| Q2 2013 | $2,948,000 | – | 46,566 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |